Coagulopathy in two patients with cystic fibrosis treated with ciprofloxacin

被引：2
|
作者：
Moore, Gillian C.
Redfern, Jan
Shiach, Caroline R.
Webb, Kevin
Jones, Andrew M.
机构：
[1] Wythenshawe Hosp, NW Lung Ctr, Manchester Adult Cyst Fibrosis Unit, Manchester M23 9LT, Lancs, England
[2] Wythenshawe Hosp, Dept Haematol, Manchester M23 9LT, Lancs, England
来源：
JOURNAL OF CYSTIC FIBROSIS | 2007年 / 6卷 / 03期
关键词：
cystic fibrosis; ciprofloxacin; coagulopathy; INR; APTT;
D O I：
10.1016/j.jcf.2006.08.002
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
We report two cases of prolonged blood clotting times as demonstrated by a raised international normalised ratio and elevated activated partial thromboplastin time in patients with cystic fibrosis taking ciprofloxacin. The potential mechanisms of a coagulopathy of this picture as an adverse drug reaction with ciprofloxacin are discussed along with the possible clinical consequences for patients with cystic fibrosis. (C) 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [21] Alginate Lyase and Ciprofloxacin Co-Immobilization on Biopolymeric Microspheres for Cystic Fibrosis Treatment
    Islan, German A.
    Bosio, Valeria E.
    Castro, Guillermo R.
    MACROMOLECULAR BIOSCIENCE, 2013, 13 (09) : 1238 - 1248
  • [22] Report of two patients with associated conditions in addition to cystic fibrosis
    Jambhekar, Supriya K.
    Carroll, John L.
    Keiles, Steven
    JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (04) : 269 - 271
  • [23] Inhalation of tobramycin in patients with cystic fibrosis:: Comparison of two methods
    Dopfer, R.
    Brand, P.
    Muellinger, B.
    Hunger, T.
    Haeussermann, S.
    Meyer, T.
    Scheuch, G.
    Siekmeier, R.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2007, 58 : 141 - 154
  • [24] INHIBITION OF CAFFEINE METABOLISM BY CIPROFLOXACIN IN CHILDREN WITH CYSTIC-FIBROSIS AS MEASURED BY THE CAFFEINE BREATH TEST
    PARKER, AC
    PRESTON, T
    HEAF, D
    KITTERINGHAM, NR
    CHOONARA, I
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (06) : 573 - 576
  • [25] Suboptimal Ciprofloxacin Dosing as a Potential Cause of Decreased Pseudomonas aeruginosa Susceptibility in Children with Cystic Fibrosis
    Guillot, Emmanuelle
    Sermet, Isabelle
    Ferroni, Agnes
    Chhun, Stephanie
    Pons, Gerard
    Zahar, Jean-Ralph
    Jullien, Vincent
    PHARMACOTHERAPY, 2010, 30 (12): : 1252 - 1258
  • [26] Efficacy of inhaled ciprofloxacin in the management of non-cystic fibrosis bronchiectasis
    Justo, Julie Ann
    Danziger, Larry H.
    Gotfried, Mark H.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2013, 7 (05) : 272 - 287
  • [27] Coagulopathy as initial manifestation of concomitant celiac disease and cystic fibrosis: A case report
    Kostovski A.
    Zdraveska N.
    Journal of Medical Case Reports, 5 (1)
  • [28] Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
    De Soyza, Anthony
    Aksamit, Timothy
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (08): : 875 - 884
  • [29] Clinical outcomes of cystic fibrosis patients with hemoptysis treated with bronchial artery embolization
    Peixoto da Silveira, Marilia Amaral
    Peixoto da Silveira, Patricia Amaral
    Beltrami, Flavia Gabe
    Scaffaro, Leandro Armani
    Roth Dalcin, Paulo de Tarso
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (04)
  • [30] The fractional excretion of sodium in patients with cystic fibrosis treated with oral sodium chloride
    Keivanfar, Majid
    Daris, Sosan
    Reisi, Mohsen
    Mehrkesh, Mehryar
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2020, 8 (06): : 185 - 190
12345